Job title: Senior Director - Biomedical Informatics & Global Head of Computational Biology Biomedical Informatics
Sándor Szalma is Global Head, Computational Biology in Takeda Pharmaceuticals. He is responsible for computational biology, computational and statistical genetics, machine learning and informatics approaches supporting target discovery and validation/reverse translation and forward translation/biomarker and patient stratification in neuroscience, gastroenterology, rare disease and oncology. He serves as a member of the governance board of Open Targets and leads the Takeda engagement in the Regeneron Whole Exome Sequencing of UK Biobank Consortium. Before joining Takeda, he was head of Translational Informatics and External Innovation, R&D IT in Janssen Research & Development, LLC. Previously, he was member of the industry advisory committee of ELIXIR, member of the board of the Pistoia Alliance, member of the Translational Medicine Advisory Committee of the PhRMA Foundation and led the Data & Knowledge Management Strategic Governance Group of Innovative Medicine Initiative. His past positions included president of MeTa Informatics, general manager of QuantumBio and senior director of Computational Biology and Bioinformatics at Accelrys, Inc. He was co-founder of Acheuron Pharmaceuticals, Inc. He lectured at UCSD Extension and was adjunct professor at Rutgers University in the Computational Biology and Molecular Biophysics program. He is the author of 45 scientific publications and book chapters and two patents. He received his doctoral degree in physical organic chemistry from A. Szent-Györgyi Medical University in Szeged, Hungary.
Panel: Big Data, Big Deal? 9:30 am
day: Day One